Global Point of Care Testing Market to reach USD 55.65 billion by 2026

Global Point of Care Testing Market Size study, by Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy & Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult Testing Products and other POC products ), by Platform (Microfluidics, Lateral Flow Assays, Dipsticks, Immunoassays, Molecular Diagnostics), by Mode (OTC-based testing and prescription-based testing), by End-user (Research Laboratories, Home Care, Professional Diagnostics Centers, Other End-Users) and Regional Forecasts 2019-2026
Product Code:  HALMD_19008833
Chapter 1.	Executive Summary  
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Point of Care Testing Market, by Product, 2017-2026 (USD Billion)
1.2.2.	Point of Care Testing Market, by Platform, 2017-2026 (USD Billion)
1.2.3.	Point of Care Testing Market, by End-User, 2017-2026 (USD Billion)
1.2.4.	Point of Care Testing Market, by Prescription Mode, 2017-2026 (USD Billion)
1.2.5.	Point of Care Testing Market, by Region, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Point of Care Testing Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Point of Care Testing Market Dynamics	
3.1.	Point of Care Testing Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Point of Care Testing Market Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Point of Care Testing Market, by Product
5.1.	Market Snapshot 
5.2.	Global Point of Care Testing Market by Product, Performance - Potential Analysis
5.3.	Global Point of Care Testing Market Estimates & Forecasts by Product, 2016-2026 (USD Billion)
5.4.	Point of Care Testing Market, Sub Segment Analysis
5.4.1.	Glucose Monitoring Products 
5.4.2.	Infectious Disease Testing Products
5.4.3.	Pregnancy and Fertility Testing Products 
5.4.4.	Coagulation Testing Products
5.4.5.	Hematology Testing Products 
5.4.6.	Drug of abuse Testing Products 
5.4.7.	Urinalysis Testing Products
5.4.8.	Cholesterol Testing Products
5.4.9.	Fecal Occult Blood Testing products 
5.4.10.	Tumor Marker Testing products
5.4.11.	Others
Chapter 6.	Global Point of Care Testing Market, by Platform
6.1.	Market Snapshot 
6.2.	Global Point of Care Testing Market by Product, Performance - Potential Analysis
6.3.	Global Point of Care Testing Market Estimates & Forecasts by Product, 2016-2026 (USD Billion)
6.4.	Point of Care Testing Market, Sub Segment Analysis
6.4.1.	Dipsticks 
6.4.2.	Lateral Flow Assays 
6.4.3.	Molecular diagnostics 
6.4.4.	Microfluidics
6.4.5.	Immunoassays
Chapter 7.	Global Point of Care Testing Market, by End-User 
7.1.	Market Snapshot 
7.2.	Global Point of Care Testing Market by End-User, Performance - Potential Analysis
7.3.	Global Point of Care Testing Market Estimates & Forecasts by End-User, 2016-2026 (USD Billion)
7.4.	Point of Care Testing Market, Sub Segment Analysis
7.4.1.	Professional Diagnostics Centers  
7.4.2.	Research Laboratories  
7.4.3.	Home Care 
7.4.4.	Other End-users
Chapter 8.	Global Point of Care Testing Market, by Prescription Mode
8.1.	Market Snapshot 
8.2.	Global Point of Care Testing Market by Prescription Mode, Performance - Potential Analysis
8.3.	Global Point of Care Testing Market Estimates & Forecasts by Prescription Mode, 2016-2026 (USD Billion)
8.4.	Point of Care Testing Market, Sub Segment Analysis
8.4.1.	Prescription-Based testing 
8.4.2.	OTC Testing
Chapter 9.	Global Point of Care Testing Market, Regional Analysis
9.1.	Point of Care Testing Market, Regional Market Snapshot 
9.2.	North America Point of Care Testing Market 
9.2.1.	U.S. Point of Care Testing Market
9.2.1.1.	Product breakdown estimates & forecasts, 2016-2026
9.2.1.2.	Platform breakdown estimates & forecasts, 2016-2026
9.2.1.3.	End-User breakdown estimates & forecasts, 2016-2026
9.2.1.4.	Prescription Mode breakdown estimates & forecasts, 2016-2026
9.2.2.	Canada Point of Care Testing Market
9.3.	Europe Point of Care Testing Market Snapshot
9.3.1.	U.K. Point of Care Testing Market
9.3.2.	Germany Point of Care Testing Market
9.3.3.	Rest of Europe Point of Care Testing Market
9.4.	Asia-Pacific Point of Care Testing Market Snapshot
9.4.1.	China Point of Care Testing Market 
9.4.2.	India Point of Care Testing Market 
9.4.3.	Japan Point of Care Testing Market
9.4.4.	Rest of Asia Pacific Point of Care Testing Market
9.5.	Latin America Point of Care Testing Market Snapshot
9.5.1.	Brazil Point of Care Testing Market
9.5.2.	Mexico Point of Care Testing Market
9.6.	Rest of The World Point of Care Testing Market
Chapter 10.	Competitive Intelligence
10.1.	Top Market Strategies
10.2.	Company Profiles
10.2.1.	Abbott Laboratories
10.2.1.1.	Overview
10.2.1.2.	Financial (Subject to Data Availability)
10.2.1.3.	Product Summary
10.2.1.4.	Recent Developments
10.2.2.	Siemens Healthineers
10.2.3.	Roche Diagnostics
10.2.4.	Becton, Dickinson and Company
10.2.5.	Quest Diagnostic
10.2.6.	Johnson & Johnson 
10.2.7.	Danaher Corporation 
10.2.8.	Siemens 
10.2.9.	Accubiotech 
10.2.10.	EKF Diagnostics
Chapter 11.	 Research Process
11.1.	Research Process
11.1.1.	Data Mining
11.1.2.	Analysis
11.1.3.	Market Estimation
11.1.4.	Validation
11.1.5.	Publishing
11.2.	Research Attributes
11.3.	Research Assumption

Global Point of care testing market valued approximately USD 25.96 billion in 2018 is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2019-2026. Healthcare decentralization coupled with the technological advancements are considered as the key growth trends for the global point of care testing market over the forecast period.

Key driving factors for the point of care testing market are high prevalence of chronic and infectious diseases along with the government support to promote point of care testing. According to the fight chronic disease organization in 2015, in U.S. 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Since point of care testing is a faster and efficient diagnostic test that offers better monitoring, diagnosis, disease management. As a result, the adoption and demand for point of care testing products would increase thereby, supplementing the growth of the market over the forecast period. Furthermore, growing awareness of point-of-care testing offers lucrative growth prospects for the point of care testing market across the globe. However, stringent government policies are expected to hinder the growth of the market during the forecast period.

On the basis of segmentation, the point of care testing market is segmented into product, platform, mode and end-user. The product segment of global point of care testing market is classified into Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy & Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult Testing Products and other POC products of which glucose monitoring testing products accounts the largest share owing to the increasing prevalence of diabetes. On the basis of platform, the market is diversified into microfluidics, lateral flow assays, dipsticks, immunoassays, molecular diagnostics. The end-user segment is classified into research laboratories, home care, professional diagnostics centers and other end-users. Also, the mode segment is bifurcated into OTC-based testing and prescription-based testing.

The regional analysis of point of care testing market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in point of care testing market owing to the high awareness amongst healthcare providers and patients regarding early disease diagnosis along with increasing healthcare expenditure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to companies engaged in exploiting the untapped opportunities.

The leading market players included in this report are-
Abbott Laboratories
Siemens Healthineers
Roche Diagnostics
Becton, Dickinson and Company
Quest Diagnostic
Johnson & Johnson
Danaher Corporation
Siemens
Accubiotech
EKF Diagnostics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Glucose Monitoring Products
Infectious Disease Testing Products
Cardiometabolic Testing Products
Pregnancy & Fertility Testing Products
Coagulation Testing Products
Tumor/Cancer Marker Testing Products
Cholesterol Testing Products
Urinalysis Testing Products
Drugs-of-Abuse Testing Products
Hematology Testing Products
Fecal Occult Testing Products
Others

By Platform
Microfluidics
Lateral Flow Assays
Dipsticks
Immunoassays
Molecular diagnostics

By Mode
OTC-based testing
Prescription-based testing

By End-user:
Research laboratories
Home care
Professional diagnostics centers
Other End Users

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
ROE
Asia Pacific
China
India
Japan
ROAPEC
LAMEA
Brazil
Mexico
ROW
Middle East & Africa

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Point of care testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…